Search alternatives:
significant linear » significant clinical (Expand Search), significant gender (Expand Search), significant level (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
linear decrease » linear increase (Expand Search)
teer decrease » mean decrease (Expand Search)
Showing 341 - 360 results of 2,508 for search '(( significantly ((teer decrease) OR (greater decrease)) ) OR ( significant linear decrease ))', query time: 0.40s Refine Results
  1. 341
    Adhesiveness changes across different IDDSI levels and food categories.

    Adhesiveness changes across different IDDSI levels and food categories. by Muxi Chen (9294270)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 342
    Statistical analysis of adhesiveness, hardness, and cohesiveness across IDDSI levels.

    Statistical analysis of adhesiveness, hardness, and cohesiveness across IDDSI levels. by Muxi Chen (9294270)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 343
    Comparison of hardness ranges for different food categories under IDDSI levels.

    Comparison of hardness ranges for different food categories under IDDSI levels. by Muxi Chen (9294270)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 344
    Assessing Bivalves as Biomonitors of Per- and Polyfluoroalkyl Substances in Coastal Environments

    Assessing Bivalves as Biomonitors of Per- and Polyfluoroalkyl Substances in Coastal Environments by Shannon E. Jones (17558652)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 345
    The effect of β-blocker treatment on renin (A) and aldosterone-to-renin ratio (B).

    The effect of β-blocker treatment on renin (A) and aldosterone-to-renin ratio (B). by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 346
    Complication subgroup analysis of the RAAS system in T2DM patients.

    Complication subgroup analysis of the RAAS system in T2DM patients. by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 347
    Flow diagram of patient selection and subgroup classification.

    Flow diagram of patient selection and subgroup classification. by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 348
    The values of angiotensin II

    The values of angiotensin II by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 349
    Spearman correlation matrix analysis of the RAAS system and glucose metabolism indexes at different hypertension subgroups.

    Spearman correlation matrix analysis of the RAAS system and glucose metabolism indexes at different hypertension subgroups. by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 350
    General characterization of T2DM patients and healthy controls.

    General characterization of T2DM patients and healthy controls. by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 351
    Antihypertensive treatment of 151 T2DM patients with hypertension at different subgroups.

    Antihypertensive treatment of 151 T2DM patients with hypertension at different subgroups. by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 352
    Spearman correlation matrix analysis of the RAAS system and glucose metabolism indexes at different normotension subgroups.

    Spearman correlation matrix analysis of the RAAS system and glucose metabolism indexes at different normotension subgroups. by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 353
    Spearman correlation matrix analysis of the RAAS system and glucose metabolism indexes in hypertensive (A) and normotensive (B) patients.

    Spearman correlation matrix analysis of the RAAS system and glucose metabolism indexes in hypertensive (A) and normotensive (B) patients. by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 354
    Change in Watt’s Connectedness Scale, Subscales by Treatment Group.

    Change in Watt’s Connectedness Scale, Subscales by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 355
    Primary and secondary efficacy end points (intention-to-treat population).

    Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 356
    Demographic and clinical characteristics of participants at baseline.

    Demographic and clinical characteristics of participants at baseline. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 357
    Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group.

    Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 358
    Change in Demoralization Scale (DSII) by Treatment Group.

    Change in Demoralization Scale (DSII) by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 359
    Change in Watt’s Connectedness Scale (WCS), General Connectedness by Treatment Group.

    Change in Watt’s Connectedness Scale (WCS), General Connectedness by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 360
    The difference of BMD between 2019 and 2022 classify by grop of urinary camium levels measured in 2019.

    The difference of BMD between 2019 and 2022 classify by grop of urinary camium levels measured in 2019. by Aroon La-up (14095691)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: